Authors’ addresses: Laarni G. Villahermosa, Tranquilino T. Fajardo, Jr., Rodolfo M. Abalos, Roland V. Cellona, Maria V. Balagon, Eduardo C. Dela Cruz, and Esterlina V. Tan, Leonard Wood Memorial Center for Leprosy Research, PO Box 727, Cebu City 6000, The Philippines. Douglas S. Walsh, Dermatology Service, Eisenhower Army Medical Center, Fort Gordon, GA 30905.
Acknowledgments: We thank the Sasakawa Memorial Health Foundation (Tokyo, Japan) for supplying World Health Organization-multi-drug therapy drugs and United Laboratories for supplying ofloxacin. We also thank Paulina Munalem, Amparo Pepito, Loida Gabiana, Guillerma Lim, and Pris Reed for support. This work was presented in part at the 15th Annual International Leprosy Congress, 1998, Beijing, People’s Republic of China.
Disclaimer: The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official or as reflecting the views of the U.S. Department of the Army or the Department of Defense.
WHO Study Group, 1982. Chemotherapy of Leprosy for Control Programmes. World Health Organ Tech Rep Ser.
WHO Expert Committee on Leprosy, Seventh Report, 1998. World Health Organ Tech Rep Ser 874.
Suneetha S, Reddy R, 2001. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy. Int J Lepr Other Mycobact Dis 69 :53–54.
Villahermosa LG, Walsh DS, Fajardo TT Jr, Abalos RM, dela Cruz EC, Veerasubramanian P, Walsh GP, 1999. Resolution of lepromatous leprosy after a short course of amoxicillin/ clavulanic acid, followed by ofloxacin and clofazimine. Int J Dermatol 38 :558–560.
Fajardo TT, Abalos RM, dela Cruz EC, Villahermosa LG, Walsh DS, Cellona RV, Balagon MV, Tan EV, Walsh GP, 1999. Clofazimine therapy for lepromatous leprosy: a historical perspective. Int J Dermatol 38 :70–74.
Ji B, Sow S, Perani E, Lienhardt C, Diderot V, Grosset J, 1998. Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients. Antimicrob Agents Chemother 42 :1115–1120.
Gupte MD, 2000. Field trials of a single dose of the combination rifampicin-ofloxacin-minocycline (ROM) for the treatment of paucibacillary leprosy. Lepr Rev 71 (Suppl):S77–S80.
World Health Organization, 1998. Model Prescribing Information: WHO Drugs Used in Leprosy. Geneva: World Health Organization, 12–14.
Mane I, Cartel JL, Grosset JH, 1997. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results. Int J Lepr Other Mycobact Dis 65 :224–229.
Ji B, Jamet P, Sow S, Perani EG, Traore I, Grosset JH, 1997. High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks. Antimicrob Agents Chemother 41 :1953–1956.
Ridley DS, 1964. Bacterial indices. Cochrane RG, Davey TF, eds. Leprosy in Theory and Practice. Baltimore: Williams and Wilkins, 620–624.
Ridley DS, Hilson GRF, 1967. A logarithmic index of bacilli in biopsies: I. method; II. evaluation. Int J Lepr Other Mycobact Dis 35 :184–192.
Pattyn S, Grillone S, 2002. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy. Lepr Rev 73 :245–247.
Reeve PA, Ala J, Hall JJ, 1992. Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy. J Trop Med Hyg 95 :266–270.
Griffiths S, Ready N, 2001. Defaulting patterns in a provincial leprosy control programme in northern Mozambique. Lepr Rev 72 :199–205.
Chen XS, Ye GY, Jiang C, Li WZ, Bian J, Wang H, Chen W, 1997. An investigation of attitudes, beliefs and behaviour of leprosy patients, family members and PHC workers towards multidrug therapy in Yangzhou and Dongtai Districts of China. Lepr Rev 68 :155–161.
Blok LM, Bloos LJ, van den Berg G, 1991. A retrospective study on seven years of multiple drug treatment for paucibacillary and multibacillary leprosy, in Bayara General Hospital, Nigeria. Lepr Rev 62 :193–200.
Gelber RH, 1994. Chemotherapy of lepromatous leprosy: recent developments and prospects for the future. Eur J Clin Microbiol Infect Dis 13 :942–952.
Rao PS, Ramachandran A, Sekar B, Ravi S, Subramanian M, 1994. Ofloxacin-containing combined drug regimens in the treatment of lepromatous leprosy. Lepr Rev 65 :181–189.